Cardiovascular Disease (CVD) Terminated Phase 3 Trials for Bococizumab (DB12456)

Also known as: Cardio Vascular Disease / Cardiovascular Diseases / Cardio-vascular Disease / Cardiovascular Disease / Cardio-vascular Diseases / Diseases, Cardiovascular / Cardiovascular disease, unspecified / Heart diseases / Cardiovascular disorder / Cardiovascular disorder NOS / Disorder cardiovascular (NOS) / Cardiovascular disorder (NOS)

IndicationStatusPhase
DBCOND0057913 (Cardiovascular Disease (CVD))Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01975389The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsPrevention
NCT02524106Bococizumab HIV Evaluation (B-HIVE) StudyTreatment
NCT01975376The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsPrevention